113 related articles for article (PubMed ID: 1970357)
1. In vitro and in vivo antitumoral activity of free, and encapsulated taxol.
Bartoli MH; Boitard M; Fessi H; Beriel H; Devissaguet JP; Picot F; Puisieux F
J Microencapsul; 1990; 7(2):191-7. PubMed ID: 1970357
[TBL] [Abstract][Full Text] [Related]
2. Effects of free and liposome-encapsulated taxol on two brain tumors xenografted into nude mice.
Riondel J; Jacrot M; Fessi H; Puisieux F; Potier
In Vivo; 1992; 6(1):23-7. PubMed ID: 1352706
[TBL] [Abstract][Full Text] [Related]
3. Liposomal vincristine preparations which exhibit decreased drug toxicity and increased activity against murine L1210 and P388 tumors.
Mayer LD; Bally MB; Loughrey H; Masin D; Cullis PR
Cancer Res; 1990 Feb; 50(3):575-9. PubMed ID: 2297698
[TBL] [Abstract][Full Text] [Related]
4. In vivo antitumor activity of the bitter melon (Momordica charantia).
Jilka C; Strifler B; Fortner GW; Hays EF; Takemoto DJ
Cancer Res; 1983 Nov; 43(11):5151-5. PubMed ID: 6616452
[TBL] [Abstract][Full Text] [Related]
5. Antitumor activity of a novel antitumor antibiotic, quinocarmycin citrate (KW2152).
Fujimoto K; Oka T; Morimoto M
Cancer Res; 1987 Mar; 47(6):1516-22. PubMed ID: 2434218
[TBL] [Abstract][Full Text] [Related]
6. Activity of the anthracycline agent, 7-con-O-methylnogarol (7-OMEN), administered orally to mice bearing P388 or L1210 leukemia.
McGovren JP
Cancer Treat Rep; 1980; 64(4-5):727-9. PubMed ID: 6448690
[TBL] [Abstract][Full Text] [Related]
7. Novel Taxol formulation: polyvinylpyrrolidone nanoparticle-encapsulated Taxol for drug delivery in cancer therapy.
Sharma D; Chelvi TP; Kaur J; Chakravorty K; De TK; Maitra A; Ralhan R
Oncol Res; 1996; 8(7-8):281-6. PubMed ID: 8938791
[TBL] [Abstract][Full Text] [Related]
8. Phase I and pharmacodynamic study of taxol in refractory acute leukemias.
Rowinsky EK; Burke PJ; Karp JE; Tucker RW; Ettinger DS; Donehower RC
Cancer Res; 1989 Aug; 49(16):4640-7. PubMed ID: 2568175
[TBL] [Abstract][Full Text] [Related]
9. Neovascular targeting therapy: paclitaxel encapsulated in cationic liposomes improves antitumoral efficacy.
Schmitt-Sody M; Strieth S; Krasnici S; Sauer B; Schulze B; Teifel M; Michaelis U; Naujoks K; Dellian M
Clin Cancer Res; 2003 Jun; 9(6):2335-41. PubMed ID: 12796403
[TBL] [Abstract][Full Text] [Related]
10. Novel self-assembling PEG-p-(CL-co-TMC) polymeric micelles as safe and effective delivery system for paclitaxel.
Danhier F; Magotteaux N; Ucakar B; Lecouturier N; Brewster M; Préat V
Eur J Pharm Biopharm; 2009 Oct; 73(2):230-8. PubMed ID: 19577643
[TBL] [Abstract][Full Text] [Related]
11. Antineoplastic activity of two taxol derivatives on an ovarian tumor xenografted into nude mice.
Riondel J; Jacrot M; Nissou MF; Picot F; Bériel H; Mouriquand C; Potier P
Anticancer Res; 1988; 8(3):387-90. PubMed ID: 2898915
[TBL] [Abstract][Full Text] [Related]
12. Activity of a novel anthracenyl bishydrazone, 9,10-anthracenedicarboxyaldehyde Bis[(4,5-dihydro-1H-imidazol-2-yl)hydrazone] dihydrochloride, against experimental tumors in mice.
Citarella RV; Wallace RE; Murdock KC; Angier RB; Durr FE; Forbes M
Cancer Res; 1982 Feb; 42(2):440-4. PubMed ID: 7055799
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of antitumor action of pyrimidinones in the treatment of B16 melanoma and P388 leukemia.
Li LH; Wallace TL; Richard KA; Tracey DE
Cancer Res; 1985 Feb; 45(2):532-8. PubMed ID: 3967227
[TBL] [Abstract][Full Text] [Related]
14. Antitumor activity of novel ailanthone derivatives in vitro and in vivo.
Kato T; Suzumura Y; Fukushima M; Honda T; Nakanishi T; Noguchi T
Anticancer Res; 1988; 8(4):573-9. PubMed ID: 3178149
[TBL] [Abstract][Full Text] [Related]
15. Antitumor activity and mechanism of action of the novel marine natural products mycalamide-A and -B and onnamide.
Burres NS; Clement JJ
Cancer Res; 1989 Jun; 49(11):2935-40. PubMed ID: 2720652
[TBL] [Abstract][Full Text] [Related]
16. Antitumoral activity of patulin and patulin-cysteine adducts.
Krivobok S; Seigle-Murandi F; Steiman R; Benoit-Guyod JL; Bartoli MH
Pharmazie; 1994 Apr; 49(4):277-9. PubMed ID: 8197228
[TBL] [Abstract][Full Text] [Related]
17. Chemotherapeutic efficacy of Nocodazole encapsulated in liposomes on L1210 murine leukemia.
Laduron C; Coune A; Atassi G; Hildebrand J; Ruysschaert JM; Stryckmans P; Brassinne C
Res Commun Chem Pathol Pharmacol; 1983 Mar; 39(3):419-36. PubMed ID: 6190203
[TBL] [Abstract][Full Text] [Related]
18. Comparison of 5-fluorouracil and ftorafur. II. Therapeutic response and development of resistance in murine tumors.
Garibjanian BT; Johnson RK; Kline I; Vadlamudi S; Gang M; Venditti JM; Goldin A
Cancer Treat Rep; 1976 Sep; 60(9):1347-61. PubMed ID: 797450
[TBL] [Abstract][Full Text] [Related]
19. Restoration of sensitivity to oxazaphosphorines by inhibitors of aldehyde dehydrogenase activity in cultured oxazaphosphorine-resistant L1210 and cross-linking agent-resistant P388 cell lines.
Sladek NE; Landkamer GJ
Cancer Res; 1985 Apr; 45(4):1549-55. PubMed ID: 3978623
[TBL] [Abstract][Full Text] [Related]
20. Novel Taxol formulations: Taxol-containing liposomes.
Straubinger RM; Sharma A; Murray M; Mayhew E
J Natl Cancer Inst Monogr; 1993; (15):69-78. PubMed ID: 7912532
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
